112 related articles for article (PubMed ID: 12910062)
1. Adrenal insufficiency and diabetes mellitus secondary to the use of topical corticosteroids for cosmetic purpose.
Sobngwi E; Lubin V; Ury P; Timsit FJ; Gautier JF; Vexiau P
Ann Endocrinol (Paris); 2003 Jun; 64(3):202-4. PubMed ID: 12910062
[TBL] [Abstract][Full Text] [Related]
2. Topical corticosteroids and secondary adrenal insufficiency: a relationship in the shade.
Márquez Pardo R; Pérez Pelayo M; Aragoneses Calvo A; Gallego Rodriguez S; Martínez Barbeito MB
Endocrinol Nutr; 2013 Nov; 60(9):e19-20. PubMed ID: 24076040
[No Abstract] [Full Text] [Related]
3. [Symptomatic adrenal insufficiency secondary to the use of cutaneous topical steroids for skin-bleaching].
Sène D; Huong-Boutin DL; Thiollet M; Barete S; Cacoub P; Piette JC
Rev Med Interne; 2008 Dec; 29(12):1030-3. PubMed ID: 18586357
[TBL] [Abstract][Full Text] [Related]
4. [Acute adrenal insufficiency after stopping prolonged corticotherapy with betnesol enemas for ulcerative colitis].
Bili H; Algayres JP; Revel F; Coutant G; Daly JP
Gastroenterol Clin Biol; 1998 Dec; 22(12):1113-4. PubMed ID: 10051992
[No Abstract] [Full Text] [Related]
5. Adrenal insufficiency as a result of long-term misuse of topical corticosteroids.
Böckle BC; Jara D; Nindl W; Aberer W; Sepp NT
Dermatology; 2014; 228(4):289-93. PubMed ID: 24751677
[TBL] [Abstract][Full Text] [Related]
6. The effect of intra-articular injection of Diprospan at the knee joint on the hypothalamic-pituitary-adrenal axis.
Habib G; Zahran R; Najjar R; Badarny S; Jabbour A; Artul S; Hakim G; Jabaly-Habib H
Swiss Med Wkly; 2015; 145():w14134. PubMed ID: 25996500
[TBL] [Abstract][Full Text] [Related]
7. Super potent topical corticosteroid use associated with adrenal suppression: clinical considerations.
Gilbertson EO; Spellman MC; Piacquadio DJ; Mulford MI
J Am Acad Dermatol; 1998 Feb; 38(2 Pt 2):318-21. PubMed ID: 9486706
[TBL] [Abstract][Full Text] [Related]
8. Generalized pustular psoriasis (von Zumbusch) following iatrogenic hypocortisolism.
Augey F; Dissard C; Normand I; Daumont M
Eur J Dermatol; 2004; 14(6):415-7. PubMed ID: 15564207
[TBL] [Abstract][Full Text] [Related]
9. Clobetasol--a potent new topical corticosteroid.
Med Lett Drugs Ther; 1986 Jun; 28(715):57-9. PubMed ID: 3520267
[No Abstract] [Full Text] [Related]
10. Topical corticosteroid-induced adrenocortical insufficiency: clinical implications.
Levin C; Maibach HI
Am J Clin Dermatol; 2002; 3(3):141-7. PubMed ID: 11978135
[TBL] [Abstract][Full Text] [Related]
11. Adrenal and pituitary functions during long-term topical steroid therapy.
Hendrikse JC; Moolenaar AJ
Dermatologica; 1972; 144(3):179-86. PubMed ID: 4640839
[No Abstract] [Full Text] [Related]
12. Adrenal suppression with intranasal betamethasone drops.
Flynn MD; Beasley P; Tooke JE
J Laryngol Otol; 1992 Sep; 106(9):827-8. PubMed ID: 1431525
[TBL] [Abstract][Full Text] [Related]
13. Pustular psoriasis with adrenal suppression following topical corticosteroids.
Tan RS
Proc R Soc Med; 1974 Aug; 67(8):719-20. PubMed ID: 4425086
[No Abstract] [Full Text] [Related]
14. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy.
McMichael AJ; Griffiths CE; Talwar HS; Finkel LJ; Rafal ES; Hamilton TA; Voorhees JJ
Br J Dermatol; 1996 Jul; 135(1):60-4. PubMed ID: 8776360
[TBL] [Abstract][Full Text] [Related]
15. [Comparative clinical trial of a new trihalogenated dermatocorticoid (halometasone) versus betamethasone dipropionate].
Schuppli R; Dressler H; Yawalkar SJ; Weirich EG
Z Hautkr; 1983 Feb; 58(4):230-7. PubMed ID: 6342285
[TBL] [Abstract][Full Text] [Related]
16. Hiccups with betamethasone dipropionate.
MacGregor EG; Villalobos R; Perini L
J Rheumatol; 2000 Mar; 27(3):819-20. PubMed ID: 10743834
[No Abstract] [Full Text] [Related]
17. Cushing's syndrome caused by topical steroid therapy for psoriasis.
Abma EM; Blanken R; De Heide LJ
Neth J Med; 2002 Apr; 60(3):148-50. PubMed ID: 12164372
[TBL] [Abstract][Full Text] [Related]
18. Guidelines for using superpotent topical steroids.
Prawer SE; Katz HI
Am Fam Physician; 1990 May; 41(5):1531-8. PubMed ID: 2333829
[TBL] [Abstract][Full Text] [Related]
19. Effect of calcipotriene plus betamethasone dipropionate topical suspension on the hypothalamic-pituitary-adrenal axis and calcium homeostasis in subjects with extensive psoriasis vulgaris: an open, non-controlled, 8-week trial.
Silver S; Tuppal R; Gupta AK; Clonier F; Olesen M; Leeder R; Taraska V
J Drugs Dermatol; 2013 Aug; 12(8):882-7. PubMed ID: 23986161
[TBL] [Abstract][Full Text] [Related]
20. Iatrogenic adrenal insufficiency associated with calcipotriol-betamethasone topical combination in psoriasis.
Giannitelli M; Maza A; Lahfa M; Meyer N; Livideanu C; Paul C
Clin Exp Dermatol; 2010 Jun; 35(4):e167-8. PubMed ID: 20089083
[No Abstract] [Full Text] [Related]
[Next] [New Search]
